<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cholesterol drugs</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Regional anesthesia technique significantly improves outcomes of hip and knee replacement</title>
   	 <description>A highly underutilized anesthesia technique called neuraxial anesthesia, also known as spinal or epidural anesthesia, improves outcomes in patients undergoing hip or knee replacement, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in the May issue of the journal Anesthesiology, found that neuraxial anesthesia, a type of regional anesthesia, reduced morbidity, mortality, length of hospital stay and costs when compared with general anesthesia.</description>
     <link>http://medicalxpress.com/news/2013-04-regional-anesthesia-technique-significantly-outcomes.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 01 May 2013 00:00:07 EST</pubDate>
	 <guid isPermaLink="false">news286563849</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/regionalanes.jpg" width="90" height="90" />
</item>
<item>
     <title>With new generic rivals, Lipitor's sales halved</title>
   	 <description>Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.</description>
     <link>http://medicalxpress.com/news/2011-12-rivals-lipitor-sales-halved.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 20 Dec 2011 05:00:02 EST</pubDate>
	 <guid isPermaLink="false">news243578929</guid>
	 
</item>
<item>
     <title>US approves India's Ranbaxy to make generic Lipitor</title>
   	 <description> Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.</description>
     <link>http://medicalxpress.com/news/2011-12-india-ranbaxy-lipitor.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 01 Dec 2011 02:11:07 EST</pubDate>
	 <guid isPermaLink="false">news241927215</guid>
	 
</item>
<item>
     <title>Pfizer's blockbuster drug Lipitor goes generic</title>
   	 <description> Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.</description>
     <link>http://medicalxpress.com/news/2011-11-pfizer-blockbuster-drug-lipitor.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 30 Nov 2011 13:31:46 EST</pubDate>
	 <guid isPermaLink="false">news241882296</guid>
	 
</item>
<item>
     <title>MRIs could become powerful tools for monitoring cholesteral therapy</title>
   	 <description>MRI scanning could become a powerful new tool for assessing how well cholesterol drugs are working, according to Loyola University Health System cardiologist Binh An P. Phan, MD.</description>
     <link>http://medicalxpress.com/news/2011-10-mris-powerful-tools-cholesteral-therapy.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 14 Oct 2011 12:52:03 EST</pubDate>
	 <guid isPermaLink="false">news237815325</guid>
	 
</item>
<item>
     <title>FDA panel to weigh revoking key use of Abbott drug</title>
   	 <description>(AP) --  A panel of advisers to the Food and Drug Administration will consider this week whether to revoke a key indication from Abbott's blockbuster cholesterol drug Trilipix.</description>
     <link>http://medicalxpress.com/news/2011-05-fda-panel-revoking-key-abbott.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 17 May 2011 13:15:45 EST</pubDate>
	 <guid isPermaLink="false">news224856838</guid>
	 
</item>


</channel>
</rss>
